# AgeX Therapeutics, Inc.: Form D filings

AgeX Therapeutics, Inc., a biotechnology company in Alameda, CA, filed 5 Form D notices with the SEC between 2017 and 2019. The latest, on March 22, 2019, reports $4.5 million sold of a $5 million offering to 17 investors.

Find out what AgeX Therapeutics, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20AgeX%20Therapeutics%2C%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=AgeX%20Therapeutics%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fagex-therapeutics-inc-1708599)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20AgeX%20Therapeutics%2C%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=AgeX%20Therapeutics%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fagex-therapeutics-inc-1708599)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in California](https://specstream.ai/data/form-d/state/california): 5,891 rows, by operating companies, filed since November 1, 2024, $138.91, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/california
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 1010 ATLANTIC AVENUE, SUITE 102, Alameda, CA, 94501
- Phone: (510) 521-3390
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Delaware
- Year incorporated: 2017
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1708599

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Mar 22, 2019 | New notice | $5,000,000 | $4,500,000 | $500,000 | 17 | Mar 11, 2019 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1708599/000146257319000001/0001462573-19-000001-index.htm) |
| Aug 27, 2018 | New notice | Indefinite | $200,000 | Indefinite | 1 | Aug 15, 2018 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1708599/000146257318000003/0001462573-18-000003-index.htm) |
| Jun 21, 2018 | New notice | $5,000,000 | $5,000,000 | $0 | 1 | Jun 6, 2018 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1708599/000146257318000002/0001462573-18-000002-index.htm) |
| Jan 31, 2018 | New notice | $1,000,000 | $462,500 | $537,500 | 20 | Jan 16, 2018 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1708599/000146257318000001/0001462573-18-000001-index.htm) |
| Jul 10, 2017 | New notice | $10,000,000 | $8,850,000 | $1,150,000 | 18 | Jun 23, 2017 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1708599/000146257317000001/0001462573-17-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Annalisa F. Jenkins | Director |  |
| Michael D. West | Executive Officer, Director |  |
| John F. Mauldin | Director |  |
| Gregory D. Bailey | Director |  |
| Not Applicable H. BioTime, Inc. | Promoter |  |
| Michael H. Mulroy | Director |  |
| Russell D. Skibsted | Executive Officer |  |

## Other biotechnology companies in California that filed recently

- [CARI Health, Inc.](https://specstream.ai/data/form-d/company/cari-health-inc-1930994) $280,000 · Nov 6, 2026
- [Ausel, Inc.](https://specstream.ai/data/form-d/company/ausel-inc-2124022) $120,000 · Nov 4, 2026
- [Trellis Bioscience, Inc.](https://specstream.ai/data/form-d/company/trellis-bioscience-inc-1162015) $9.1 million · Oct 29, 2026
- [BigHat Biosciences, Inc.](https://specstream.ai/data/form-d/company/bighat-biosciences-inc-1797256) $75.1 million · Oct 26, 2026
- [Theravie Pharma, Inc.](https://specstream.ai/data/form-d/company/theravie-pharma-inc-2160768) $750,000 · Oct 19, 2026
- [Adela, Inc.](https://specstream.ai/data/form-d/company/adela-inc-1852167) $12 million · Oct 19, 2026
- [Estuary Biotherapeutics, Inc.](https://specstream.ai/data/form-d/company/estuary-biotherapeutics-inc-2138862) $40.7 million · Oct 16, 2026
- [Renue Life Sciences, Inc.](https://specstream.ai/data/form-d/company/renue-life-sciences-inc-2158207) $250,000 · Oct 14, 2026
- [Tempest Therapeutics, Inc.](https://specstream.ai/data/form-d/company/tempest-therapeutics-inc-1544227) $7.5 million · Oct 14, 2026
- [Lionheart Health, Inc.](https://specstream.ai/data/form-d/company/lionheart-health-inc-2156758) $387,500 · Oct 7, 2026
- [Rakuten Medical, Inc.](https://specstream.ai/data/form-d/company/rakuten-medical-inc-1595215) $9 million · Oct 6, 2026
- [Zonaliz, Inc.](https://specstream.ai/data/form-d/company/zonaliz-inc-2157556) $2.5 million · Oct 5, 2026
- [Altay Therapeutics, Inc.](https://specstream.ai/data/form-d/company/altay-therapeutics-inc-2157551) $15.7 million · Oct 2, 2026
- [Sialia Therapeutics, Inc.](https://specstream.ai/data/form-d/company/sialia-therapeutics-inc-2156754) $1.5 million · Sep 29, 2026
- [Vetmab Biosciences, Inc.](https://specstream.ai/data/form-d/company/vetmab-biosciences-inc-1932050) $11.4 million · Sep 29, 2026

[Every Form D from the week of Mar 18, 2019](https://specstream.ai/data/form-d/week/2019-03-18) · [All recent filings in California](https://specstream.ai/data/form-d/state/california) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what AgeX Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).